Tag Archives: Diabetes

New Research Reveals Link Between High Blood Sugar and Upper Limb Problems

(IN BRIEF) A recent study led by the University of Exeter has identified a connection between consistently high blood sugar levels and upper limb conditions such as frozen shoulder, Dupuytren’s disease, carpal tunnel syndrome, and trigger finger. The research, conducted … Read the full press release

IQ Biozoom Innovates Non-Invasive Self-Testing, Empowering People to Self-Monitor with Laboratory Precision at Home

(IN BRIEF) IQ Biozoom, a medical technology startup, is developing non-invasive home diagnostics that allow people to measure the concentration of biochemical substances in liquid analytes like saliva, sweat, urine, or tears. Their technology integrates inkjet printing with advanced semiconductors, … Read the full press release

Novo Nordisk’s Bid for BIOCORP Set at 35.00 Euros per Share, Totaling 154 Million Euros

(IN BRIEF) Novo Nordisk A/S is in exclusive negotiations to acquire a controlling stake in BIOCORP Production SA, a French company specializing in medical device design and manufacturing. The acquisition would be followed by a mandatory tender offer for all … Read the full press release

Novo Nordisk and Aspect Biosystems collaborate to create disease-modifying treatments for diabetes and obesity

(IN BRIEF) Novo Nordisk has announced a collaboration with Aspect Biosystems to develop bioprinted tissue therapeutics for diabetes and obesity treatment. The collaboration will leverage Aspect’s bioprinting technology and Novo Nordisk’s expertise in stem cell differentiation and cell therapy development … Read the full press release

Danish Novo Nordisk to use millions of liters of sustainable aviation fuel to replace fossil fuel for all Kuehne+Nagel air freight shipments in 2022

12 million litres of SAF (sustainable aviation fuel) to minimise environmental impact of Novo Nordisk air freight globally Sustainable fuel offering to support customers’ pledge for carbon-neutral shipping Advocating for more sustainable fuel production and use (PRESS RELEASE) SCHINDELLEGI, 20-Oct-2022 … Read the full press release

Danish Novo Nordisk utilizará millones de litros de combustible de aviación sostenible para reemplazar el combustible fósil para todos los envíos de carga aérea de Kuehne+Nagel en 2022

12 millones de litros de SAF (combustible de aviación sostenible) para minimizar el impacto ambiental de la carga aérea de Novo Nordisk a nivel mundial Oferta de combustible sostenible para respaldar el compromiso de los clientes de envíos sin emisiones … Read the full press release

12-month real-world achievements for Diabeloop’s Automated Insulin Delivery (AID):

4 million1 hours of hypoglycemia avoided Trust in the algorithm leads to fewer meal declarations Users report a significantly reduced mental load (PRESS RELEASE) PARIS, 21-Sep-2022 — /EuropaWire/ — Diabeloop, a leader in therapeutic AI applied to insulin delivery, reports … Read the full press release

Diabeloop, a key player in therapeutic AI applied to insulin delivery, announces 70 million euros new financing round to accelerate its international expansion

High-growth diabetes company Diabeloop closes its Series C financing round – led by LBO France, joined by Terumo Corporation, Innovacom and backed by Diabeloop’s historical partners – to power the company’s commercial roll-out and global expansion. (PRESS RELEASE) PARIS, 2-Jun-2022 … Read the full press release

Diabeloop presents new real-life results of DBLG1® System: Confirmed improvement in Time In Range +18.4 percentage points; Reduction of time spent in hypoglycemia to only 0.9%

(PRESS RELEASE) PARIS, 28-Apr-2022 — /EuropaWire/ — ATTD 2022 – Diabeloop, pioneer in therapeutic artificial intelligence for diabetes management, presents today new results from a real-life cohort in Germany. The data show a constant improvement in Time In Range (70-180 … Read the full press release

Diabeloop adapts its self-learning, personalized insulin automatization software to be used with insulin pens

(PRESS RELEASE) PARIS, 12-Apr-2022 — /EuropaWire/ — Diabeloop, a pioneer in the field of therapeutic artificial intelligence, leverages the potential of its diabetes technology to enable the integration of insulin pens into its hybrid closed-loop system using a unique app. … Read the full press release

University of Exeter led research may be at the doorstep of finding a treatment for the common diabetes complication hypoglycaemia

(PRESS RELEASE) EXETER, 17-Dec-2021 — /EuropaWire/ — University of Exeter, a public research university in Exeter, Devon, South West England, United Kingdom, has announced that a research that it led together with Rigel Pharmaceuticals (NASDAQ: RIGL), a biotech firm dedicated … Read the full press release

Significant improvement in increasing Time In Range and reducing hypoglycemia among people equipped with Diabeloop DBLG1

EASD 2021 – Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, is presenting new real-world data(1) of its Automated Insulin Delivery system, DBLG1. The personalized device fine-tunes insulin delivery using a state-of-the-art algorithm. Thousands of European patients have … Read the full press release

De zelflerende algoritme DBLG1®: eenvoudig te gebruiken voor een optimale en gepersonaliseerde behandeling van diabetes type 1

(PRESS RELEASE) PARIJS, 2-Jun-2021 — /EuropaWire/ — Vanaf het begin heeft Diabeloop innovatieve systemen ontwikkeld om de behandeling van diabetes type 1 te automatiseren en te personaliseren, waarbij altijd rekening wordt gehouden met de optiek van de patiënt. Het Franse … Read the full press release

Sanofi launches more impactful Corporate Social Responsibility (CSR) strategy

Accelerating projects on access to medicines, support for vulnerable communities, environmental conservation, and diversity and inclusion Creation of Sanofi Global Health, global nonprofit unit to provide 40 of the world’s poorest countries access to 30 essential medicines (PRESS RELEASE) PARIS, 7-Apr-2021 — … Read the full press release

Technical University of Munich scientists described a new class of designed macrocyclic peptides that are highly potent inhibitors of amyloid formation

MUNICH, 14-Aug-2018 — /EuropaWire/ — Effective therapeutics to counteract the formation of amyloid plaques in Alzheimer’s disease and type 2 diabetes are not yet available. Scientists at the Technical University of Munich (TUM) have now come a little bit closer to … Read the full press release

KTH researchers produced microparticles with encapsulated cells that can be used as implants to fight cancer, diabetes or heart disease

STOCKHOLM, 18-Apr-2018 — /EuropaWire/ — One way that cancer may be fought in the future is with micro-sized capsules containing living cells engineered to secrete toxins that attack cancer cells. Although the science of cell micro-encapsulation has yet to overcome certain … Read the full press release

Dr Will Johnson of Loughborough University: the concept of ‘healthy obesity’ is inherently flawed

Leicestershire, UK, 17-Apr-2018 — /EuropaWire/ — The on-going debate over whether ‘health obesity’ exists is diverting attention away from effective medical research as academics continue to use the confusing classification. The concept – which relates to people with high BMI but … Read the full press release

Diabetes: US FDA approval for Medtronic’s Guardian(TM) Connect continuous glucose monitoring (CGM) system

 ‘Smart’ CGM System Provides Predictive Alerts for Dangerous Sensor Glucose Levels; Exclusive Access to Sugar.IQ Assistant with Watson Offers More Proactive Diabetes Management DUBLIN, 13-Mar-2018 — /EuropaWire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, services and solutions, today announced it received … Read the full press release

Medtronic at the Advanced Technologies & Treatments for Diabetes (ATTD) 11th International Conference in Vienna, Austria, February 14-17

Medtronic Will Host an Exclusive Symposium on Thursday, February 15 VIENNA, 14-Feb-2018 — /EuropaWire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced its schedule of notable sessions that will be presented at the Advanced Technologies & Treatments for … Read the full press release

University of Exeter’s Professor Andrew Hattersley earns CBE for his work in diabetes research

EXETER, 09-Feb-2018 — /EuropaWire/ — A world-leading diabetes expert today (Thursday 8th February) received his CBE for his work in revolutionising global diagnosis and treatment. Andrew Hattersley, Professor of Molecular Medicine at the University of Exeter and a diabetes consultant at the Royal Devon … Read the full press release

University of Dundee: Smoking and diabetes are leading risk factors for peripheral artery disease (PAD)

research also points to diabetes as cause of disease that can lead to limb amputation DUNDEE, 20-Sep-2017 — /EuropaWire/ — Smoking and diabetes are the two leading risk factors for peripheral artery disease (PAD), a narrowing of the arteries which can … Read the full press release

Medtronic presented results of iPro2 Professional CGM at 9th International Conference on Advanced Technologies & Treatments for Diabetes

iPro2 Professional CGM Provides Information to Help Physicians Optimize Care for Their Patients Regardless of Their Diabetes Therapy MILAN, 08-Feb-2016 — /EuropaWire/ — A retrospective analysis of the iPro2 Professional CGM from Medtronic plc (NYSE:MDT), the global leader in medical technology, … Read the full press release

University of Aberdeen: UK and US scientists made major step forward in understanding how the brain senses low glucose levels

For people suffering from diabetes, managing blood sugar can be like walking a tightrope – if too high they run the risk of serious long term complications such as blindness, kidney failure, limb gangrene and premature heart disease, but allow … Read the full press release

University of Leicester led team published new findings about the link between low blood glucose and cardiovascular events

International team led by University of Leicester publish new findings Leicester, UK, 15-12-2014 — /EuropaWire/ — A study involving scientists from the University of Leicester has established a link between hypoglycaemia and increased risk of cardiovascular events and mortality in … Read the full press release

Sanofi and Medtronic partner to improve patient experience and outcomes for people with diabetes around the world

Initial focus on insulin-device combinations and care management services Paris and Minneapolis, Minn., 16-6-2014 — /EuropaWire/ — Sanofi (EURONEXT: SAN and NYSE: SNY) and Medtronic, Inc. (NYSE: MDT) today announced that they have signed a memorandum of understanding to enter into a … Read the full press release

HumEn project received €6M EU grant to develop stem cell-based treatment of diabetes

STEM CELLS A grant of 6 million euros for the HumEn project brings together leading European stem cell-research groups and industrial partners in a coordinated and collaborative effort aimed at developing glucose-responsive, insulin-producing beta cells for future cell-replacement therapy in diabetes. … Read the full press release

University of Leicester health research led by Professor Kamlesh Khunti received £28.4M funding to speed up impact for patients across East Midlands

12-8-2013 — /EuropaWire/ — Research led by University of Leicester health expert aims to speed up impact for patients across the region Issued by Nottinghamshire Heathcare NHS Trust on 9 August 2013 A collaboration between the NHS and universities across the … Read the full press release

Boehringer Ingelheim and Eli Lilly presented clinical trials results evaluating linagliptin efficacy and safety in Asians with Type 2 Diabetes

2-7-2013 — /europawire.eu/ — New Phase III data presented at the American Diabetes Association 73rd Scientific Sessions® (ADA) showed linagliptin improved blood glucose control as monotherapy and in combination with metformin, in Asian people from China, Malaysia and the Philippines with … Read the full press release

Boehringer Ingelheim, Lilly released results of new meta-analysis regarding CV events in linagliptin Phase 3 trials presented at the American Diabetes Association

Ingelheim, Germany and Indianapolis, US, 1-7-2013 — /europawire.eu/ — Boehringer Ingelheim and Eli Lilly and Company today announced results from a new analysis of Phase III data demonstrating that treatment with the dipeptidyl peptidase-4 (DPP-4) inhibitor linagliptin is not associated with … Read the full press release

EU Health Prize for Journalists seeks to reward excellence in health journalism, now open to 28 European countries

Brussels, 14-6-2013 — /europawire.eu/ — Today, the virtual doors swing open to journalists from across the EU wishing to participate in the annual EU Health Prize for Journalists. Winners can pick up EU-wide recognition and cash prizes for excellence in health journalism, … Read the full press release

Bayer HealthCare supports Middle East, North Africa and Europe diabetes projects under the “Excellence across Borders” program

Leverkusen, 12-6-2013 — /europawire.eu/ — Bayer HealthCare supports local projects under the “Excellence across Borders” program in order to improve care of people with diabetes. Among the projects is a Diabetic School Awareness Program in the Kingdom of Saudi Arabia, which … Read the full press release